Eosinophil counts in peripheral blood, serum total IgE, eosinophil cationic protein, IL-4 and soluble E-selectin in atopic dermatitis

Korean Journal of Dermatology

Volumn 40, Issue 11, 2002, Pages 1367-1373

  Kim, Myeung Nam ^a   Shin, Bong Ju ^a   Tak, Woo Jung ^a   Ro, Byung In ^a   Park, Ae Ja ^a  

^a Chung Ang University   (South Korea)

Author keywords

Atopic dermatitis; Eosinophil cationic protein; Soluble E selectin

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; INTERLEUKIN 4;

ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; RATING SCALE; SCORAD INDEX;

EID: 0036880655     PISSN: 04944739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128-137
2. Bos JD, Wierenga EA, Sillevis JH, Heijden FL, Kapsenberg ML. Immune dysregulation in atopic eczema. Arch Dermatol 1992;128:1509-1512
3. Gunar S, Johanson O, Juhlin L. Immunoglobulin E in "healed" atopic dermatitis and after treatment with corticosteroids and azathioprine. Br J Dermatol 1970;82: 10-13
4. Uehara M, Izukura R, Sawai T. Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 1990;15:264-266
5. Kang K, Tian R. Atopic dermatitis. An evaluation of clinical and laboratory findings. Int J Dermatol 1987;26: 27-32
6. Stone SP, Muller SA, Gleich GJ. IgE levels in atopic dermatitis. Arch Dermatol 1973;108:806-811
7. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-2357
8. Venge P. Eosinophil and neutrophil granulocytes. Allergy 1993;48:39-47
9. Ackerman SJ, Loegering DA, Venge P, Olsson I, Harley JB, Fauci AS, et al. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol 1983;131:2977-2982
10. Czech W, Schopf E, Kapp A. Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis-correlation with disease activity. Br J Dermatol 1996;134:17-21
11. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venerol 1980;92:44-47
12. Rajka G. Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol 1989;144:13-4
13. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997;195:10-19
14. Waller PF. Eosinophilia. J Allergy Clin Immunol 1984; 73:1-11
15. Clendenning WE, Clack WE, Ogawa M, Ishizaka K. Serum IgE studies in atopic dermatitis. J Invest Dermatol 1973;61:213-236
16. Kaliner M, Lemanske R. Rhinitis and asthma. JAMA. 1992;268:2807-2829
17. Czech W, Krutmann J, Schopf E, Kapp A. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 1992;126:351-355
18. Kapp A. The role of eosinophils in the pathogenesis of atopic dermatitis -eosinophil granule proteins as markers of disease activity. Allergy 1993;48:1-5
19. Kagi MK, Joller JH, Wuthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 1992;185:88-92
20. Tang M, Kemp A, Varigos G. IL-4 and interferon-gamma production in children with atopic disease. Clin Exp Immunol 1993;92:120-124
21. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94:870-876
22. Petzelbauer P, Bender JR, Wilson J, Pober JS. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 1993;151:5062-72
23. Kowalzick L, Kleinheinz A, Neuber K, Weichenthal M, Kohler I, Ring J. Elevated serum levels of soluble adhesion molecules ICAM-1 and ELAM-1 in patients with severe atopic eczema and influence of UVA1 treatment. Dermatology 1995;190:14-8
24. Yamashita N, Kaneko S, Kouro O, Furue M, Yamamoto S, Sakane T. Soluble E-selectin as a marker of disease activity in atopic dermatitis. J Allergy Clin Immunol 1997; 99:410-416
25. Leung DY. Atopic dermatitis: New insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860-876
26. Koide M, Furukawa F, Tokura Y, Shirahama S, Takigawa M. Evaluation of soluble cell adhesion molecules in atopic dermatitis. J Dermatol 1997;24:88-93
27. Furue M, Koga T, Yamashita N. Soluble E-selectin and eosinophilic cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis. Br J Dermatol 1999;140:67-72